BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

ImQuest BioSciences

ImQuest BioSciences, Inc. is one of the world's leading providers of services ranging from anti - infective drug and vaccine discovery and complete preclinical therapeutic development to basic initiatives in microbiology research. Our technical and professional expertise includes microbiology (virology, bacteriology, mycology), molecular biology, cell biology, immunology, flow cytometry and tissue culture. Our multidisciplinary approach to infectious disease and cancer research allows for the rapid development of technologically current and novel programs that are required to solve the research problems of your drug development program.


Contact Details:
7340 Executive Way Suite R
Frederick
Maryland
21704
United States of America
Tel:301-696-0274
Fax:301-696-0381
Email:
WWW:

www.imquest.com/




Loading...

Recent Publications by ImQuest BioSciences:

Comparative evaluation of virus transmission inhibition by dual-acting pyrimidinedione microbicides using the microbicide transmission and sterilization assay.
In the absence of a fully effective human immunodeficiency virus (HIV)...
19th June, 2008
ImQuest BioSciences, Inc., 7340 Executive Way, Suite R, Frederick, MD Antimicrob Agents Chemother. 2008 Aug;52(8):2787-96. Epub 2008 Jun 16.
DOI Direct Link
Comparative evaluation of the inhibitory activities of a series of pyrimidinedione congeners that inhibit human immunodeficiency virus types 1 and 2.
Seventy-three analogs of SJ-3366...
7th May, 2008
ImQuest BioSciences, Inc., 7340 Executive Way, Suite R, Frederick, MD Antimicrob Agents Chemother. 2008 Jan;52(1):225-36. Epub 2007 Oct 29.
DOI Direct Link
The structure-activity relationships of 2,4(1H,3H)-pyrimidinedione derivatives as potent HIV type 1 and type 2 inhibitors.
Since the discovery of the 2,4 (1H,3H)-pyrimidinediones as potent...
15th January, 2008
ImQuest BioSciences, Antivir Chem Chemother. 2007;18(5):259-75.
Synthesis and biological evaluation of alkenyldiarylmethane HIV-1 non-nucleoside reverse transcriptase inhibitors that possess increased hydrolytic stability.
Non-nucleoside inhibitors of HIV reverse transcriptase (NNRTIs), albeit...
6th December, 2007
Department of Medicinal Chemistry and Molecular Pharmacology, School of J Med Chem. 2007 Oct 4;50(20):4854-67. Epub 2007 Sep 6.
DOI Direct Link
The 17th International Conference on Antiviral Research.
The focus of the 17th International Conference on Antiviral Research was...
22nd July, 2005
ImQuest BioSciences, Inc., 7340 Executive Way, Suite R, Frederick, Expert Opin Investig Drugs. 2004 Sep;13(9):1207-12.
DOI Direct Link

View more ImQuest BioSciences research publications.

BioNews Results for ImQuest BioSciences:

Arisyn acquires portfolio of small molecule inhibitors from UTR
Pharmaceutical Business Review:  Sep 25 2008 7:34AM Matching: imquest biosciences

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 185 times since April 2007, the link to the organisation's website has been followed 40 times

Recent Search Terms used to find this page: ImQuest | ImQuest BioSciences | t | imquest | imquest biosciences | t | imquest biosciences | imquest | imquest biosciences | .

Search for more companies in Frederick

Search for more companies in Maryland



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for ImQuest BioSciences

  Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2008 - BioPortfolio Limited.